Pear Therapeutics exploring sale, other ‘strategic alternatives’
Prescription digital therapeutics company Pear Therapeutics is exploring “strategic alternatives,” including a possible company sale, merger, or acquisition. In a press release, the company said it hired a financial advisor to look into actions that could “maximize shareholder value.” That includes a potential sale, M&A, divestiture of assets, licensing or other strategic transactions. It may …
Pear Therapeutics exploring sale, other ‘strategic alternatives’ Read More »